# Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study

> **NCT06645275** · PHASE4 · NOT_YET_RECRUITING · sponsor: **RenJi Hospital** · enrollment: 416 (estimated)

## Conditions studied

- Anticoagulation

## Interventions

- **GENETIC:** POCT test

## Key facts

- **NCT ID:** NCT06645275
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 416 (ESTIMATED)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06645275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06645275, "Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06645275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*